Abstract
The relationship of the serotonin transporter gene promoter region polymorphism (5-HTTLPR) to antidepressant response was examined in 95 elderly patients receiving a protocolized treatment for depression with paroxetine or nortriptyline. Patients were treated for up to 12 weeks and assessed weekly with clinical ratings and measurements of plasma drug concentrations. Twenty-one of the paroxetine-treated subjects were found to have the ll genotype and 30 had at least one s allele. There were no baseline differences between these groups in pretreatment Hamilton Rating Scale for Depression (HRSD) scores or anxiety symptoms. During acute treatment with paroxetine, mean reductions from baseline in HRSD were significantly more rapid for patients with the ll genotype than for those possessing an s allele, despite equivalent paroxetine concentrations. Onset of response to nortriptyline was not affected. Allelic variation of 5-HTTLPR may contribute to the variable initial response of patients treated with a selective serotonin reuptake inhibitor.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP . (1996): A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1: 453–460
Edenberg HJ, Reynolds J . (1998): Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4). Psychiatric Genetics 8: 193–195
First MB, Spitzer RL, Gibbon M, Williams JBW . (1997): Structured Clinical Interview for DSM-IV Axis I Disorders SCID I: Clinician Version, Administration Booklet. Washington, DC, American Psychiatric Press
Foglia JP, Sorisio D, Kirshner M, Pollock BG . (1997): Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection. J Chromatogr Biol Med Appl 693: 147–151
Folstein MF, Folstein SE, McHugh PR . (1975): Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198
Hamilton M . (1967): Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278–296
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP . (1996): Allelic variation of human serotonin transporter gene expression. J Neurochemistry 66: 2621–2624
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL . (1996): Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527–1531
Mulsant BH, Pollock BG, Nebes R, Miller M, Little J, Stack J, Reynolds CF . (1999): A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life: Six-week outcome. J Clin Psychiatry 60(suppl 20): 16–20
Pollock BG, Everett G, Peril J . (1992): Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites. Neuropsychopharmacology 6: 1–10
Serretti A, Cusin C, Lattuada E, DiBella D, Catalano M, Smeraldi E . (1999): Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry 4: 280–283
Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M . (1998): Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3: 508–511
Young RC, Karaviorgou M, Kalayam B, Hull J, Alexopoulos GS . (1999): Serotonin transporter promoter polymorphism and response to nortriptyline in geriatric major depression. Society for Neuroscience Meeting, 29th Annual Meeting, Miami Beach, FL. Abstract 533.17.
Acknowledgements
This work was supported by U.S. Public Health Service Grants MH01509, MH01613, MH52247, MH30915, and AG05133.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pollock, B., Ferrell, R., Mulsant, B. et al. Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression. Neuropsychopharmacol 23, 587–590 (2000). https://doi.org/10.1016/S0893-133X(00)00132-9
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(00)00132-9
Keywords
This article is cited by
-
Kynurenine pathway and white matter microstructure in bipolar disorder
European Archives of Psychiatry and Clinical Neuroscience (2018)
-
Personalized medicine in psychiatry: problems and promises
BMC Medicine (2013)
-
Serotonin transporter genotype and function in relation to antidepressant response in Koreans
Psychopharmacology (2013)
-
A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People
Drug Safety (2012)
